The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
123866064 12386606 4 F 2014 20160721 20160519 20160726 EXP US-BIOGEN-2014BI027640 BIOGEN 50.60 YR F Y 0.00000 20160726 MD US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
123866064 12386606 1 PS TYSABRI NATALIZUMAB 1 Intravenous (not otherwise specified) INFUSED OVER 1 HOUR U 125104 300 MG CONCENTRATE FOR SOLUTION FOR INFUSION
123866064 12386606 2 SS TYSABRI NATALIZUMAB 1 Unknown U 125104 UNKNOWN

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
123866064 12386606 1 Multiple sclerosis

Outcome of event

Event ID CASEID OUTC COD
123866064 12386606 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
123866064 12386606 Central nervous system lesion
123866064 12386606 Dementia
123866064 12386606 Depression
123866064 12386606 Diplegia
123866064 12386606 Dysarthria
123866064 12386606 Dysphagia
123866064 12386606 Fear
123866064 12386606 Groin pain
123866064 12386606 Hallucination, visual
123866064 12386606 Hypoaesthesia
123866064 12386606 Memory impairment
123866064 12386606 Mobility decreased
123866064 12386606 Multiple sclerosis relapse
123866064 12386606 Musculoskeletal stiffness
123866064 12386606 Nightmare
123866064 12386606 Peripheral swelling
123866064 12386606 Speech disorder
123866064 12386606 Thrombosis
123866064 12386606 Urinary tract infection

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
123866064 12386606 1 20101110 20140117 0